Nasdaq IPOs

The IPO market is feeling the effects of the coronavirus outbreak with a surge in the VIX volatility index weighing on IPO activity. Since 2015, a week in which VIX volatility has surpassed 35 has been followed by a week averaging two US IPO pricings. Our observational trend con

Procore Technologies, which provides cloud-based construction management and collaboration software, filed on Friday with the SEC to raise up to $100 million in an initial public offering, though this is likely a placeholder for a deal we estimate could raise up to $400 million.

NLS Pharmaceutics, an early-stage biotech focusing on therapies for CNS and sleep disorders, filed on Friday with the SEC to raise up to $40 million in an initial public offering. The Stans, Switzerland-based company was founded in 2015 and plans to list on the Nasdaq under the

Accolade, which provides a platform that helps employees manage their healthcare benefits, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The Seattle, WA-based company was founded in 2007 and booked $123 million in sales for the 12 months

ORIC Pharmaceuticals, a Phase 1 biotech developing small molecule therapies for cancer, filed on Friday with the SEC to raise up to $86 million in an initial public offering. The South San Francisco, CA-based company was founded in 2014 and plans to list on the Nasdaq under the

Social Capital Hedosophia Holdings III, the third blank check company formed by Social Capital and Hedosophia targeting ex-US tech, filed on Friday with the SEC to raise up to $600 million in an initial public offering. The Palo Alto, CA-based company plans to raise $600 million

Social Capital Hedosophia Holdings III, a second blank check company formed by Social Capital and Hedosophia targeting ex-US tech, filed on Friday with the SEC to raise up to $600 million in an initial public offering. The Palo Alto, CA-based company plans to raise $600 million

Social Capital Hedosophia Holdings II, the second blank check company formed by Social Capital and Hedosophia targeting US tech, filed on Friday with the SEC to raise up to $300 million in an initial public offering. The Palo Alto, CA-based company plans to raise $300 million by

Pulmonx, which makes minimally invasive medical devices for emphysema, filed on Friday with the SEC to raise up to $86 million in an initial public offering. The Redwood City, CA-based company was founded in 1996 and booked $33 million in sales for the 12 months ended December 3

NLS Pharmaceutics, which is developing controlled-release formulations of approved drugs for ADHD and narcolepsy, filed on Tuesday with the SEC to raise up to $40 million in an initial public offering. The Stans, Switzerland-based company was founded in 2015 and plans to list on

Hitek Global, which provides IT consulting and solutions services in China, raised the proposed deal size for its upcoming IPO on Friday. The Xiamen, China-based company now plans to raise $15 million by offering 3 million shares at a price range of $4 to $6. The company had pre

Passage Bio, a preclinical biotech developing gene therapies for rare CNS disorders, raised $216 million by offering an upsized 12 million shares at $18, the high end of the range of $16 to $18. Earlier on Thursday, Passage Bio increased its proposed offering to 10 million share

ZoomInfo Technologies, which provides a data platform for sales, marketing, and recruiting professionals, filed on Thursday with the SEC to raise up to $500 million in an initial public offering. Formerly known as DiscoverOrg, the company was renamed ZoomInfo Technologies follow

ZoomInfo Technologies, which provides a data platform for sales, marketing, and recruiting professionals, filed on Thursday with the SEC to raise up to $500 million in an initial public offering. Formerly known as DiscoverOrg, the company was renamed ZoomInfo Technologies follow

ZoomInfo Technologies, which provides a data platform for sales, marketing, and recruiting professionals, filed on Thursday with the SEC to raise up to $500 million in an initial public offering. Formerly known as DiscoverOrg, the company was renamed ZoomInfo Technologies follow

Passage Bio, a preclinical biotech developing gene therapies for rare CNS disorders, increased the proposed share offering for its upcoming IPO on Thursday. The Philadelphia, PA-based company now plans to raise $170 million by offering 10 million shares at a price range of $16 t

The coronavirus outbreak may shut down most of the IPO market, with volatility spiking and the Renaissance IPO Index down 4.6% this week, but not all companies are caught in the headwinds. There are several bright spots, including recent biotech IPOs, defensive names, and viru

GigCapital3, the third blank check company from semiconductor veteran Avi Katz, filed on Tuesday with the SEC to raise up to $200 million in an initial public offering. GigCapital3 is calling itself a Private-to-Public Equity (PPE) company, a term its sponsor has trademarked. Th

GigCapital3, the third blank check company from semiconductor veteran Avi Katz, filed on Tuesday with the SEC to raise up to $200 million in an initial public offering. GigCapital3 is calling itself a Private-to-Public Equity (PPE) company, a term its sponsor has trademarked. Th

GFL Environmental, North America's fourth-largest diversified waste management firm, relaunched its IPO with a lowered range on Tuesday. The Vaughan, Canada-based company now plans to raise $1.5 billion by offering 73.2 million shares (2% insider) at a price range of $2